Caplight Directory>Investors>Kineticos Disruptor Fund>Kineticos


Kineticos Disruptor Fund

Kineticos Disruptor Fund

Raleigh, North Carolinakineticos.com

Overview

The Kineticos Disruptor Fund is a life sciences investment fund that invests in disruptive modalities including cell therapy approaches such as CAR Ts, TCRs, TILs, gene therapy, gene editing, RNAi, immuno-oncology, and related precision medicine technologies. The Kineticos Disruptor Fund will focus on large, unmet medical needs in oncology, neurosciences and rare diseases. Kineticos will support entrepreneur-scientists and the biotech community through Series A funding.

Year Founded

2020

Portfolio Companies

3

Investments

CompanyDateStageLead
EnterobiotixApr 2024Early FundingCo-investor
EnterobiotixSep 2021Series ACo-investor
InceptorJun 2021SeedLead
PromaxoMay 2020Series B ExtensionLead

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersRaleigh, North Carolina
Year Founded2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.